Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-73,075
Closed -$6.26M 3934
2025
Q4
$6.25M Buy
+73,075
New +$6.11M 0.02% 680
2025
Q3
Sell
-3,614
Closed -$330K 2976
2025
Q2
$366K Sell
3,614
-121,462
-97% -$12.4M ﹤0.01% 1759
2025
Q1
$13.3M Buy
+125,076
New +$13M 0.08% 178
2024
Q1
Sell
-36,972
Closed -$3.45M 2438
2023
Q4
$3.45M Buy
36,972
+24,320
+192% +$2.25M 0.03% 430
2023
Q3
$1.12M Sell
12,652
-157,178
-93% -$16.2M 0.01% 907
2023
Q2
$19.1M Buy
+169,830
New +$20.2M 0.18% 71
2022
Q3
Sell
-11,015
Closed -$536K 2910
2022
Q2
$536K Buy
+11,015
New +$669K 0.01% 1426
2022
Q1
Sell
-91,353
Closed -$8.64M 3223
2021
Q4
$11.7M Buy
91,353
+64,510
+240% +$9.94M 0.07% 137
2021
Q3
$3.85M Sell
26,843
-69,288
-72% -$9.51M 0.02% 413
2021
Q2
$11.2M Buy
96,131
+84,041
+695% +$8.27M 0.1% 169
2021
Q1
$972K Sell
12,090
-9,661
-44% -$736K 0.01% 1196
2020
Q4
$1.36M Buy
+21,751
New +$1.24M 0.03% 475
2019
Q4
Sell
-22,701
Closed -$630K 1224
2019
Q3
$630K Buy
22,701
+6,068
+36% +$147K 0.03% 557
2019
Q2
$328K Buy
+16,633
New +$385K 0.02% 519

Other funds holding CROX

HRT Financial's CROX Position: Q1 2026 in Review

HRT Financial sold out of Crocs (CROX) in Q1 2026, closing a stake of 73,075 shares — an estimated $6.26M sold.

HRT Financial first reported a position in CROX in Q2 2019 and held it in 14 quarters. The position peaked at $19.1M in Q2 2023. 456 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

  • HRT Financial reported no remaining Crocs position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 73,075 Crocs shares in Q1 2026, an estimated $6.26M.
  • HRT Financial first reported a position in Crocs in Q2 2019 and held it in 14 quarters.
  • HRT Financial's Crocs position peaked at $19.1M in Q2 2023.
  • 456 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.